Dr. Mena Milad, MD

Dr. Milad practices at East Texas Surgery Center in Sulphur Springs, Texas.

Dr. Milad's NPI, 1912265968, was assigned on April 27, 2012. Dr. Milad graduated from UT Southwestern Medical Center in 2012. Dr. Milad holds Texas license Q3053.

Dr. Milad's primary practice is East Texas Surgery Center, at 1402 Medical Drive, Sulphur Springs, TX 75482. The practice phone is (903) 487-2248.

Dr. Milad's primary practice is East Texas Surgery Center in Sulphur Springs, Texas. Dr. Milad is also affiliated with Hunt Regional Medical Center Greenville. The medical group on file is Texas Modern Gastroenterology. Dmand AI also links Dr. Milad to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Milad practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Milad's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Milad is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Milad is licensed in Texas.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroduodenitis, gastroenteritis and gastrointestinal bleeding among the conditions Dr. Milad treats.

CMS data shows 731 Medicare services from Dr. Milad across 11 procedure codes in 2024, for 350 Medicare patients. Medicare paid $82,476 for them.

CMS counts 350 Medicare patients who saw Dr. Milad in 2024. The largest group is 65 to 74, with 186 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Milad's median patient age at 65, with 49% women.

In 2024, Dr. Milad wrote 1,033 Medicare Part D claims for 427 patients. 76% of them were for generic drugs. CMS names the drug for 887 of them, across 14 drugs with 11 or more claims each, at $205,140 in total drug cost. In 2023, CMS named 800 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Milad for performance year 2024, reported individually. Dr. Milad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 162 procedures of colonoscopy by Dr. Milad, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Milad, published from 2014 to 2019. 2019 was the busiest year, with 2. Dr. Milad's most frequent co-authors are Syed Tahsin Ahmed, DO, Nancy Soraya Behazin, MD and Mark A. Jeffries, DO.

CMS Open Payments shows 221 general payments to Dr. Milad from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. Olympus Corporation of the Americas paid the most, $2,204.

Dr. Milad graduated from UT Southwestern Medical Center in 2012.

Dr. Milad is in network with 18 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.